Skip to main content

Find Clinical Trials

Home
Conditions
First Relapse

Clinical trial condition

First Relapse

Explore clinical trials studying First Relapse. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

First Relapse trial results

Recruiting

Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma

NCT06252792

Conditions: Blood Protein Disorders, Cardiovascular Diseases, First Relapse, +13 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Completed

A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial (PCD)

NCT02244125

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: CHRU Hopital Sud Amiens, France

Centre Hospitalier de la côte Basque Bayonne, France

Hôpital Avicenne Bobigny, France

ICH - Hôpital A. Morvan Brest, France

View all 30 locations

View Trial Details